Showing results (81-90 of 125) with videos related to
Sort By:
Pageof 13
Biorxiv : the Preprint Server for Biology|September 15, 2025
Transcriptional Rewiring of BET Inhibitor Treated Ewing Sarcoma Cells Augments their Dependency on Focal Adhesion KinaseShireen S Ganapathi, Emma D Wrenn, Nicolas M Garcia, et al.Frontiers in Oncology|March 23, 2013
A Decade in Banking Ewing Sarcoma: A Report from the Children's Oncology GroupScott C Borinstein, Natalie Beeler, John J Block, et al.Pediatric Blood & Cancer|June 15, 2016
Comparison of clinical features and outcomes in patients with extraskeletal versus skeletal localized Ewing sarcoma: A report from the Children's Oncology GroupThomas Cash, Elizabeth McIlvaine, Mark D Krailo, et al.Public Health Nutrition|January 24, 2024
Parliamentary reaction to the announcement and implementation of the UK Soft Drinks Industry Levy: applied thematic analysis of 2016-2020 parliamentary debatesCatrin P Jones, Emma R Lawlor, Hannah Forde, et al.Obesity Reviews : an Official Journal of the International Association for the Study of Obesity|October 26, 2020
The impact of adult behavioural weight management interventions on mental health: A systematic review and meta-analysisRebecca A Jones, Emma R Lawlor, Jack M Birch, et al.Journal of Sport and Health Science|January 11, 2020
Adolescents' perspectives on a school-based physical activity intervention: A mixed method studyStephanie T Jong, Caroline H D Croxson, Cornelia Guell, et al.Cancer Research|July 2, 2016
Activation of Wnt/β-Catenin in Ewing Sarcoma Cells Antagonizes EWS/ETS Function and Promotes Phenotypic Transition to More Metastatic Cell StatesElisabeth A Pedersen, Rajasree Menon, Kelly M Bailey, et al.Frontiers in Genetics|November 7, 2013
A comprehensive promoter landscape identifies a novel promoter for CD133 in restricted tissues, cancers, and stem cellsRamakrishna Sompallae, Oliver Hofmann, Christopher A Maher, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 24, 2010
Current treatment protocols have eliminated the prognostic advantage of type 1 fusions in Ewing sarcoma: a report from the Children's Oncology GroupJohn A van Doorninck, Lingyun Ji, Betty Schaub, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 5, 2010
Ewing tumors that do not overexpress BMI-1 are a distinct molecular subclass with variant biology: a report from the Children's Oncology GroupAaron Cooper, John van Doorninck, Lingyun Ji, et al.Pageof 13